Back to results
US 2023/0127345 A1Published application
Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof
AssigneeGalectin Sciences, LLC
InventorsSharon Shechter, Eliezer Zomer, Peter G. Traber, Raphael Nir, Joseph M. Johnson, Ryan George
Life of this patent
Estimating the term…
Abstract
Aspects of the invention relate to novel synthetic compounds having a binding affinity with galectin proteins.
Claims17
A compound of Forn a (5) or a pharmaceutically acceptable salt or solvate thereof
A composition comprising:
- a therapeutically effective amount of a compound of Formula (5)
- or a pharmaceutically acceptable salt or solvate thereof;
- and
- a pharmaceutically acceptable adjuvant, excipient, formulation carrier or a combination thereof.
1 more element
A method for treating a disorder relating to the binding of a galectin to a ligand, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (5)
- or a pharmaceutically acceptable salt or solvate thereof.
Dependencies are inferred from the claim text.